VAERS Reports EN6202, EN6202

VAERS 1832961

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6202, EN6202

moderat

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 18.03.2021
Beginn: 20.10.2021
Tage bis Beginn: 216,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase increased Anion gap Aspartate aminotransferase increased Base excess Basophil percentage Blood albumin decreased Blood alkaline phosphatase increased Blood bicarbonate decreased Blood bilirubin increased Blood calcium normal Blood chloride increased Blood creatinine increased Blood gases Blood glucose normal Blood lactate dehydrogenase increased Blood magnesium normal Blood methaemoglobin Blood pH normal

Symptomtext

SOB, low O2 saturation. His wife recently tested positive for COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Lab Results: Other Chemistry: 20-Oct-21 04:35, Brain Natriuretic Peptide Brain Natriuretic Peptide 63 [10 - 100 pg/ml] A cutoff of 100 pg/mL has been demonstrated to provide the maximal combination of sensitivity, specificity, and negative predictive value for contributing to the diagnosis of congestive heart failure (CHF). A BNP value greater than 100 pg/mL is consistent with a diagnosis of CHF in the appropriate clinical setting. Blood concentrations of natriuretic peptides may also be elevated in patients with myocardial infarction and in patients who are candidates for or are undergoing renal dialysis. 20-Oct-21 04:35, Chemistry 14 Profile Estimated GFR 36.44 [60.00 - 130. ml/ min] Estimated Glomerular Filtration Rate 30.11 [60.00 - 130. ml/ min] Estimated GFR Value <60 ml/min/1.73 sq meters is indicative of chronic kidney disease <15 ml/min/1.73 sq meters is indicative of kidney failure The Estimated GFR is calculated by the four variable MDRD equation. Limitations of this calculation include: Decreased accuracy for values >60 Decreased accuracy in the hospitalized/severely ill patient populations Disregard EGFR values for infants and children (should not be applied to this age group) 20-Oct-21 04:35, Magnesium Level, Serum Magnesium Level, Serum 1.7 [1.6 - 2.6 mg/dL] 20-Oct-21 04:35, Troponin I Troponin I 0.02 [0.00 - 0.03 ng/mL] Normal: <= 0.03 ng/mL Indeterminate: 0.04-0.29 ng/mL Suggestive of Myocardial Damage: >= 0.30 ng/mL ABG & VBG: 20-Oct-21 04:40, Venous Blood Gas Request *FIO2 6L NC Coagulation: 20-Oct-21 04:35, D Dimer D Dimer 1069 [0 - 500 ng/mL FCU] This D-Dimer method is FDA approved for exclusion of both deep vein thrombosis (DVT) and pulmonary embolism (PE) at a cut-off value of 500 ng/mL FEU when the clinical probability of DVT or PE is low (e.g. when assessed by Wells or Modified Geneva scores). Additionally the cut-off value for PE exclusion can be age adjusted upwards for patients greater than 50 years old by multiplying the patient's age by 10 (e.g. 78 y/o patient would have an upper limit of 780 ng/mL FEU). 20-Oct-21 04:35, PT Protime Protime. 12.7 [10.1 - 12.5 sec] INR 1.14 [0.80 - 1.20] Therapeutic range for DVT, PE and prophylactic use 2.0-3.0 Therapeutic range for high risk patients and mechanical heart valve patients 2.5-3.5 20-Oct-21 04:35, PTT PTT 32 [26 - 39 sec] CBC-Differential-Morphology: 20-Oct-21 04:35, CBC White Blood Cell Count 10.4 [4.5 - 11.0 K/cmm] Red Blood Cell Count 5.16 [3.90 - 5.60 M/cmm] Hemoglobin 15.3 [12.0 - 17.3 g/dL] Hematocrit 45.1 [36.0 - 53.0 %] Mean Corpuscular Volume 87.5 [80.0 - 100.0 fl] Mean Corpuscular Hemoglobin 29.7 [26.0 - 34.0 PG] Mean Corpuscular Hemoglobin Concn 33.9 [31.0 - 37.0 %] Red Cell Distribution Width 13.8 [11.5 - 14.5 %] *Platelet Count 164 [140 - 440 K/cmm] Mean Platelet Volume 9.2 [7.4 - 10.4 FL] Automated Neutrophils % 91 [ %] Automated Lymphocytes % 3 [ %] Automated Monocytes % 6 [ %] Automated Eosinophils % 0 [ %] Automated Basophils % 0 [ %] Absolute Neutrophil Count 9.5 [1.0 - 8.0 K/cmm] Absolute Lymphocyte Count 0.3 [1.0 - 5.0 K/cmm] Absolute Monocyte Count 0.6 [0.1 - 0.8 K/cmm] Chemistry Panels & Profiles: 20-Oct-21 04:35, Chemistry 14 Profile Sodium Level, Serum 141 [136 - 144 mmol/L] Potassium Level, Serum 3.9 [3.6 - 5.1 mmol/L] Chloride Level, Serum 111 [101 - 111 mmol/L] Total Carbon Dioxide, Serum 17 [20 - 30 mmol/L] Blood Urea Nitrogen, Serum 39 [8 - 26 mg/dL] Creatinine Level, Serum 2.15 [0.61 - 1.24 mg/dL] Anion Gap 13 [8 - 16 mmol/L] Glucose, Serum 164 [70 - 99 mg/dL] The above reference range for glucose is appropriate for the fasting state. For random specimens, values up to 140 mg/dL are considered normal. Calcium Level, Serum 9.0 [8.4 - 10.2 mg/dL] Albumin Level, Serum 3.1 [3.5 - 5.0 g/dL] Phosphorus Level, Serum 1.3 [2.3 - 4.7 mg/dL] Bilirubin, Total 1.1 [0.3 - 1.0 mg/dL] Protein Total Level, Serum 6.5 [6.5 - 8.1 g/dL] Aspartate Aminotransferase (SGOT) 92 [15 - 41 U/L] Alanine Aminotransferase (SGPT) 52 [17 - 63 U/L] Alkaline Phosphatase, Serum 155 [41 - 150 U/L] Lactic Dehydrogenase (LDH), Serum 411 [125 - 220 IU/L] VBGs: 20-Oct-21 04:40, Venous Blood Gas Request pH. 7.382 [7.320 - 7.42] pCO2. 35.1 [41.0 - 51.0 mm Hg] pO2. 41.3 [37.0 - 43.0 mm Hg] O2 Saturation 71.9 [70.0 - 76.0 %] Actual Bicarbonate. 20.4 [ mmol/L] Hemoglobin, Total. 15.8 [13.3 - 17.1 g/dL] *Carboxyhemoglobin Saturation. 1.5 [ %] Oxygen Content. 15.9 [17.5 - 23.0 Vol %] Methemoglobin.. 0.8 [ %] Base Excess. -3.4 [0.0 - 2.0 mmol/L] Chest xray 1 view
Aktuelle Erkrankungen: unknown
Vorgeschichte: HLD, asthma
Andere Medikamente: unknown
Allergien: no known allergies
Vorherige Impfungen: -